Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nerissa A. Lewis"'
Publikováno v:
Inorganic Chemistry. 56:9781-9793
Our goal is to develop convenient methods for obtaining trans-[PtII(4-Xpy)2Cl2] complexes applicable to 4-substituted pyridines (4-Xpy) with limited volatility and water solubility, properties typical of 4-Xpy, with X being a moiety targeting drug de
Publikováno v:
Inorganic chemistry. 56(16)
Our goal is to develop convenient methods for obtaining trans-[Pt
Autor:
LaMaryet Moody, Jason Olaivar, Nerissa A. Lewis, Alvin A. Holder, Rahul L. Khade, Amit Kumar, Vijayaraghavan Rangachari, Yong Zhang
Publikováno v:
ACS Chemical Neuroscience. 1:691-701
Design of inhibitors for amyloid-β (Aβ) peptide aggregation has been widely investigated over the years towards developing viable therapeutic agents for Alzheimer's disease (AD). The biggest challenge seems to be inhibiting Aβ aggregation at the e
Publikováno v:
Inorganic chemistry. 53(20)
New mononuclear amidine complexes, fac-[Re(CO)3(Me2bipy)(HNC(CH3)(pyppz))]BF4 [(4,4'-Me2bipy (1), 5,5'-Me2bipy (2), and 6,6'-Me2bipy (3)] (bipy = 2,2'-bipyridine), were synthesized by treating the parent fac-[Re(I)(CO)3(Me2bipy)(CH3CN)]BF4 complex wi
Autor:
Floyd A. Beckford, Anthony R. Magnusen, Luke Seymour, Frank R. Fronczek, Nerissa A. Lewis, Don VanDerveer, Fange Liu, Antonio González-Sarrías, Jessa Faye Arca, Alvin A. Holder, Navindra P. Seeram, Aimin Liu, William L. Jarrett, Travis R. Erves, Ramaiyer Venkatraman
[VO(Sal-L-tryp)(H2O)] 1 (where sal-L-tryp = N-salicylidene-L-tryptophanate) was used as a precursor to produce the novel complexes, [VO(Sal-L-tryp)(MeATSC)].1.5C2H5OH 2 (where MeATSC = 9-Anthraldehyde-N(4)-methylthiosemicarbazone), [VO(Sal-L-tryp)(N-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e282890eedebd393ec50104d6a9e3d45
https://europepmc.org/articles/PMC3725831/
https://europepmc.org/articles/PMC3725831/